NASDAQ | ETF
The fund is an ETF that seeks to meet its objective by having Corgi Strategies, LLC actively manage the fund and, under ordinary market conditions, invest at least 80% of its net assets (plus any borrowings for investment purposes) in a portfolio of companies materially involved in the research, development, and commercialization of genomics and precision medicine technologies that enable improved disease detection, identifying and grouping patients based on genetic, molecular, or clinical characteristics to guide treatment decisions, targeted therapies, and data-driven healthcare.
It is non-diversified.
Top 10 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 8.76% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 6.97% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.48% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 3.99% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 3.75% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 3.62% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 3.01% |
| GMAB | Genmab AS | Healthcare | Biotechnology | 2.97% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.90% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 2.72% |